Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 12 | $3,819,614 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 02 Oct 2024 16:37 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 30 Sep 2024 | Sale | 30,000 | 29.03 | 870,900 | D |
| 22 Aug 2024 16:15 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 20 Aug 2024 | Sale | 1,727 | 23.79 | 41,085 | D |
| 03 Jul 2024 21:13 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 01 Jul 2024 | Sale | 100 | 22.8 | 2,280 | D |
| 03 Jul 2024 21:13 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 01 Jul 2024 | Sale | 29,900 | 22.12 | 661,388 | D |
| 03 Jul 2024 21:13 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 13 Jun 2024 | Sale | 688 | 21.79 | 14,992 | D |
| 02 Apr 2024 18:07 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 01 Apr 2024 | Sale | 92,500 | 20.5 | 1,896,250 | D |
| 15 Feb 2024 21:16 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 13 Feb 2024 | Sale | 2,750 | 17.29 | 47,548 | D |
| 09 Jan 2024 19:34 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 05 Jan 2024 | Sale | 3,208 | 19.43 | 62,331 | D |
| 23 Aug 2023 16:31 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 21 Aug 2023 | Sale | 1,419 | 22.6 | 32,069 | D |
| 15 Feb 2023 19:02 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 13 Feb 2023 | Sale | 2,119 | 30.1 | 63,782 | D |
| 10 Feb 2023 18:10 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 08 Feb 2023 | Sale | 1,377 | 30.88 | 42,522 | D |
| 09 Jan 2023 21:42 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 05 Jan 2023 | Sale | 2,970 | 28.44 | 84,467 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)